These little pills save lives – and promise success in treating Covid-19.
© Christin Klose / dpa
A study with 4,400 participants found: Those who take a certain drug are less likely to die of a coronavirus infection.
- A meaningful study result: If people take a blood thinner such as aspirin, their risk of dying from Covid-19 is reduced.
- American researchers conclude this after evaluating the data from almost 4,400 coronavirus patients. A current study also comes to this conclusion.
- Find out how here Taking blood thinners such as heparin or aspirin and the course of Covid-19 disease related.
Update from October 30th, 2020: Aspirin prevents severe Covid-19 courses
Ironically, an everyday medication that almost everyone has at home is supposed to prevent severe coronavirus infections: US researchers conclude in a newly published study. Jonathan Chow from the University of Maryland in Baltimore and his team have analyzed how taking aspirin and thus taking the blood-thinning agent acetylsalicylic acid (ASA) affects the course of the disease. The patients who were treated with low dose acetylsalicylic acid before they were infected with Sars-CoV-2, expected a significantly milder course of their Covid 19 disease than people who had not taken ASA.
As part of the observational study, the disease progression of 98 Covid-19 patients treated with aspirin and 314 people without ASA treatment was compared. The former had a 44 percent lower risk of mechanical ventilation and 43 percent less time had to be transferred to an intensive care unit. According to the researchers, one reason for this lies in the blood clot-preventing effect of acetylsalicylic acid. In severe cases of Covid-19, blood clots (thromboses) * often occur, which are often blamed for death, informs the Ärzteblatt. But studies must follow that clearly demonstrate the benefits of aspirin against Covid-19. The researchers advise against taking aspirin without a doctor’s recommendation, as aspirin also has side effects.
To the study
Medicines reduce the risk of dying from Covid-19 – thousands of people take it every day
Article from October 14, 2020: How exactly a coronavirus infection affects the body has not yet been conclusively clarified. But some studies have come to the conclusion that Covid-19 can be associated with thrombosis * – with sometimes fatal consequences. “It has long been known in clinics that thromboembolic events are a common complication of Covid-19“, so the assessment of Uwe Janssens, President of the German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) in Berlin. Treatment recommendations have already been published, quoted the editorial network Germany (RND) on.
And this is where a drug comes into play that can protect against thrombosis: so-called Blood thinners with the active ingredients heparin or acetylsalicylic acid (e.g. contained in aspirin) Their anticoagulant properties reduce the risk of blood clots forming in arteries and veins. Anticoagulant drugs are used in the following patients, among others:
- People with advanced arterial calcification
- People who have a congenital tendency towards increased blood clotting
- as a supplement to the therapy of heart attacks, strokes and embolisms
- in people who have had a thrombosis
- Before, after and during surgery, when the patient has to lie in bed for a long time
In an experiment, US researchers had also used blood thinners on Covid 19 patients – they published their results in the Journal of the American College of Cardiology. Almost 4,400 patients were divided into three groups for the study: One received no blood thinners, the second group was given a high dose of blood thinners, and the third group received a low dose, which is also used to prevent thrombosis.
also read: German researchers find bad new corona consequence – fit, young people also affected.
Therapy with blood thinners: Patients need less artificial ventilation
“There was a strong association between blood thinners and a reduced likelihood of hospital death: both therapeutic and prophylactic doses of anticoagulant drugs reduced mortality by about 50 percent compared to patients who were not given blood thinners, “says a statement from the Mount Sinai Hospital Group that participated in the study.
In addition, the risk of artificial ventilation also decreased in both groups, as reported by the RND. Patients who were given a high dose of blood thinners had to be connected to a ventilator 31 percent less often, and those who received a prophylactic dose 28 percent less often. The extent to which the therapy with blood thinners could be incorporated into the Covid-19 treatment as standard is still being discussed. (jg) * Merkur.de is part of the Germany-wide Ippen-Digital editorial network.
Continue reading: Medicines against Covid-19: “Veklury” should make coronavirus patients healthy faster.
These viruses and bacteria make us sick



Source link by https://www.rosenheim24.de/gesundheit/aspirin-coronavirus-medikament-gegen-covid-19-blutverduenner-arzneimittel-therapie-behandlung-zr-90034054.html
*The article has been translated based on the content of Source link by https://www.rosenheim24.de/gesundheit/aspirin-coronavirus-medikament-gegen-covid-19-blutverduenner-arzneimittel-therapie-behandlung-zr-90034054.html
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
These were the details of the news Corona: drug lowers risk of dying from Covid-19 – thousands of... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at en24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.